Sjögren’s syndrome is associated with a significantly increased risk of miscarriage and other adverse outcomes during pregnancy, a recent study reports. The study, “A meta-analysis of the effect of Sjögren’s syndrome on adverse pregnancy outcomes,” was published in the journal Clinics. Sjögren’s syndrome mainly affects…
News
A low dose treatment of interleukin-2 (IL-2), an immune signaling protein, improved salivary gland function in a Sjögren’s syndrome mouse model, but it didn’t reverse immune-mediated structural damage to the glands, a study showed. Although IL-2 may improve salivary gland function in Sjögren’s, combining it with other immunomodulatory therapies…
Motto Health has launched a type of virtual clinic — with rheumatologists and healthcare professionals — for people with autoimmune and chronic inflammatory conditions, including Sjögren’s syndrome, the startup announced. Through an online application, the platform allows patients to schedule virtual appointments with specialists, manage and track symptoms,…
People with a history of herpes zoster infection, mainly those with no other health conditions, are at an increased risk of developing Sjögren’s syndrome, according to a nationwide, population-based study in Taiwan. Its researchers emphasized the importance of screening for Sjögren’s in patients with herpes zoster infection, particularly among…
Age, disease duration, and blood levels of inflammatory markers Krebs von den Lungen-6 (KL-6) and TNF-alpha are the most discriminating factors for identifying Sjögren’s syndrome patients with interstitial lung disease, a study found. While less significantly associated, other inflammatory markers, including immunoglobulin M (IgM), c-reactive protein (CRP), eotaxin, and…
Sugar metabolism — all chemical reactions involved in making or breaking down glucose, or blood sugar — is overly active in B-cells, a type of immune cell implicated in Sjögren’s syndrome, and may provide a target for developing treatments, a study suggests. The study, “mTORC1-GLUT1-mediated glucose metabolism drives…
People with Sjögren’s syndrome are more likely to require inpatient hospital care for infections acquired in the community, especially those of the airways and intestines, according to a large nationwide French study. “[Sjögren’s] patients had a significantly higher incidence rate of hospitalization for bronchopulmonary infections compared with matched [healthy…
Cytotoxic CD8+ T-cells, a type of immune cells, build up in the salivary glands of the lips of patients with severe Sjögren’s syndrome, where they may kill the epithelial cells that line the glands, according to a new study. As these cells die, the glands no longer can produce…
A protein called ETS1 is present in large amounts in cells in the salivary glands of patients with Sjögren’s syndrome, where it may turn on a switch to make more of MMP-9, another protein that has been implicated in the early development of the disease, a study found. Researchers…
The investigational therapy dazodalibep markedly eased disease activity in people with Sjögren’s syndrome with moderate-to-high systemic disease activity, meeting the primary goal of a Phase 2 trial. Ahead of expectations, the therapy’s developer, Horizon Therapeutics, plans to work with the U.S. Food and Drug Administration (FDA) to design…
Recent Posts
- Salivary duct treatment eases dry mouth in Sjögren’s disease: Study
- 4 genes linked to inflammatory cell death very active in Sjögren’s
- AI can see what doctors miss to accurately diagnose Sjögren’s
- Worse fatigue tied to more pain in people with Sjögren’s, study finds
- Dazodalibep therapy now in Phase 3 testing for Sjögren’s disease
- Sjögren’s treatment ianalumab shows rapid disease relief in trials
- Sjögren’s patients on nipocalimab report less pain, dryness in trial
- Ouro starts Phase 1b trial of OM336 for Sjögren’s disease treatment
- Telitacicept eases Sjögren’s disease activity in Phase 3 trial
- Machine learning tool may help in diagnosing primary Sjögren’s